From: Role of LncRNA score and PVT1 in primary hyperparathyroidism-- a preliminary study
Parameters | PC (n = 11) | PA (n = 46) | P-value |
---|---|---|---|
Age (SD) (years) | 58.0 (11.6) | 58.3 (13.4) | 0.871 |
Sex (% M) | 63.6 | 28.3 | 0.038* |
Disease course (SD) (month) | 96.3 (135.2) | 65.5 (81.2) | 0.690 |
Calcium (SD) (Ca2+; mmol/L) | 3.11 (0.50) | 2.80 (0.33) | 0.056 |
Albumin adjusted Ca2+(SD) (mmol/L) | 3.15 (0.52) | 2.79 (0.35) | 0.040* |
P (SD)(mmol/L) | 0.80 (0.42) | 0.85 (0.38) | 0.551 |
ALP (SD)(U/L) | 150.7 (66.0) | 187.5 (291.2) | 0.151 |
Maximum diameter (SD)(cm) | 2.89 (1.27) | 2.14 (1.29) | 0.075 |
lncRNA score (SD) | 99.17 (56.7) | 37.8 (10.0) | 0.000* |
PVT1(SD) | 3.59 (3.68) | 1.00 (3.46) | 0.000* |